Nem differenciált collagenosis 2009-ben

Translated title of the contribution: Undifferentiated connective tissue disease

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Evolution of immunopathological diseases is usually slow and progressive. Non-differentiated collagen disease (NDC) or the term "undifferentiated connective tissue disease" (UCTD) represents a stage of disease where clinical symptoms and serological abnormalities suggest autoimmune disease, but they are not sufficient to fulfill the diagnostic criteria of any well-established connective tissue disease (CTD) such as systemic lupus erythematosus (SLE), Sjögren's syndrome, mixed connective tissue disease (MCTD), systemic sclerosis (SSc), polymyositis/ dermatomyositis (PM/DM) or rheumatoid arthritis (RA). 30-40 percent of patients presenting undifferentiated profile develops and reaches the stage of a well defined systemic autoimmune disease during five years follow up, while 60 percent remains in an undifferentiated stage.In the stage of NDC, immunoregulatory abnormalities and endothelial dysfunction are present. In conclusion, NDC represents a dynamic state, and it is important to recognize the possibility of a progression to a definite systemic autoimmune disease.

Original languageHungarian
Pages (from-to)867-872
Number of pages6
JournalOrvosi Hetilap
Volume150
Issue number19
DOIs
Publication statusPublished - May 1 2009

Fingerprint

Collagen Diseases
Connective Tissue Diseases
Autoimmune Diseases
Mixed Connective Tissue Disease
Dermatomyositis
Systemic Scleroderma
Systemic Lupus Erythematosus
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nem differenciált collagenosis 2009-ben. / Bodolay, E.; Szegedi, G.

In: Orvosi Hetilap, Vol. 150, No. 19, 01.05.2009, p. 867-872.

Research output: Contribution to journalArticle

@article{92fe8af8b9224e21a46e3e8bed2d9541,
title = "Nem differenci{\'a}lt collagenosis 2009-ben",
abstract = "Evolution of immunopathological diseases is usually slow and progressive. Non-differentiated collagen disease (NDC) or the term {"}undifferentiated connective tissue disease{"} (UCTD) represents a stage of disease where clinical symptoms and serological abnormalities suggest autoimmune disease, but they are not sufficient to fulfill the diagnostic criteria of any well-established connective tissue disease (CTD) such as systemic lupus erythematosus (SLE), Sj{\"o}gren's syndrome, mixed connective tissue disease (MCTD), systemic sclerosis (SSc), polymyositis/ dermatomyositis (PM/DM) or rheumatoid arthritis (RA). 30-40 percent of patients presenting undifferentiated profile develops and reaches the stage of a well defined systemic autoimmune disease during five years follow up, while 60 percent remains in an undifferentiated stage.In the stage of NDC, immunoregulatory abnormalities and endothelial dysfunction are present. In conclusion, NDC represents a dynamic state, and it is important to recognize the possibility of a progression to a definite systemic autoimmune disease.",
keywords = "Diagnosis, Disease course, Prognosis, Therapy, Undifferentiated connective tissue disease",
author = "E. Bodolay and G. Szegedi",
year = "2009",
month = "5",
day = "1",
doi = "10.1556/OH.2009.28610",
language = "Hungarian",
volume = "150",
pages = "867--872",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "19",

}

TY - JOUR

T1 - Nem differenciált collagenosis 2009-ben

AU - Bodolay, E.

AU - Szegedi, G.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Evolution of immunopathological diseases is usually slow and progressive. Non-differentiated collagen disease (NDC) or the term "undifferentiated connective tissue disease" (UCTD) represents a stage of disease where clinical symptoms and serological abnormalities suggest autoimmune disease, but they are not sufficient to fulfill the diagnostic criteria of any well-established connective tissue disease (CTD) such as systemic lupus erythematosus (SLE), Sjögren's syndrome, mixed connective tissue disease (MCTD), systemic sclerosis (SSc), polymyositis/ dermatomyositis (PM/DM) or rheumatoid arthritis (RA). 30-40 percent of patients presenting undifferentiated profile develops and reaches the stage of a well defined systemic autoimmune disease during five years follow up, while 60 percent remains in an undifferentiated stage.In the stage of NDC, immunoregulatory abnormalities and endothelial dysfunction are present. In conclusion, NDC represents a dynamic state, and it is important to recognize the possibility of a progression to a definite systemic autoimmune disease.

AB - Evolution of immunopathological diseases is usually slow and progressive. Non-differentiated collagen disease (NDC) or the term "undifferentiated connective tissue disease" (UCTD) represents a stage of disease where clinical symptoms and serological abnormalities suggest autoimmune disease, but they are not sufficient to fulfill the diagnostic criteria of any well-established connective tissue disease (CTD) such as systemic lupus erythematosus (SLE), Sjögren's syndrome, mixed connective tissue disease (MCTD), systemic sclerosis (SSc), polymyositis/ dermatomyositis (PM/DM) or rheumatoid arthritis (RA). 30-40 percent of patients presenting undifferentiated profile develops and reaches the stage of a well defined systemic autoimmune disease during five years follow up, while 60 percent remains in an undifferentiated stage.In the stage of NDC, immunoregulatory abnormalities and endothelial dysfunction are present. In conclusion, NDC represents a dynamic state, and it is important to recognize the possibility of a progression to a definite systemic autoimmune disease.

KW - Diagnosis

KW - Disease course

KW - Prognosis

KW - Therapy

KW - Undifferentiated connective tissue disease

UR - http://www.scopus.com/inward/record.url?scp=67249138175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249138175&partnerID=8YFLogxK

U2 - 10.1556/OH.2009.28610

DO - 10.1556/OH.2009.28610

M3 - Article

C2 - 19403430

AN - SCOPUS:67249138175

VL - 150

SP - 867

EP - 872

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 19

ER -